Clinical Trial Update: The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure [Phase 3]

View source ↗

Summary

Phase 3 trial investigating sedation strategies to maximize efficacy and reduce neurological dysfunction and mortality in septic patients with acute respiratory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Impaired Cognition
• Sepsis

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Sepsis, Delirium | Phase 3 | Status: COMPLETED | Results posted: 2021-06-07